(Q45865848)

17 December 2017

title

Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus (English)

1 reference

17 December 2017

1 reference

1 reference

1 reference

1 reference

W Zhou

1

1 reference

17 December 2017

H Zhu

2

1 reference

17 December 2017

W Chen

3

1 reference

17 December 2017

X Hu

4

1 reference

17 December 2017

X Pang

5

1 reference

17 December 2017

J Zhang

6

1 reference

17 December 2017

X Huang

7

1 reference

17 December 2017

B Fang

8

1 reference

17 December 2017

C He

9

1 reference

17 December 2017

publication date

24 December 2010

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

18

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

336-345

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/cgt.2010.83

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

The TRAIL to selective tumor death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

China approves world's first oncolytic virus therapy for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

A severe combined immunodeficiency mutation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

A new model of patient tumor-derived breast cancer xenografts for preclinical assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Stromal fibroblasts in cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

The tumour microenvironment as a target for chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Replicative retroviral vectors for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Gene therapy for malignant glioma: current clinical status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Oncolytic viruses in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

Adjuvant treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

inferred from DOI database lookup

7 January 2021

based on heuristic

Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

inferred from DOI database lookup

7 January 2021

based on heuristic

Induced apoptosis supports spread of adenovirus vectors in tumors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.83

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2010.83

1 reference

17 December 2017

Dimensions Publication ID

1041489916

0 references

1 reference

17 December 2017